EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome

Simon Faissner iD, Jeremias Motte iD, Melissa Sgodzai, Christian Geis iD, Aiden Haghikia iD, Dimitrios Mougiakakos, Dominic Borie iD, Roland Schroers iD, Ralf Gold iD

Proceedings of the National Academy of Sciences · 25.06.2024 · 121 (26)

DOI: 10.1073/pnas.2403227121 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.06.2024. Verfasst von Simon Faissner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum 44791, Germany. Hauptthemen laut MEDLINE: Stiff-Person Syndrome, Immunotherapy, Adoptive, Antigens, CD19. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rose Foundation, Nasch family.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment with autologous chimeric antigen receptor (CAR) T cells has emerged as a highly effective approach in neuroimmunological disorders such as myasthenia gravis. We report a case of successful anti-CD19 CAR T cell use in treatment-refractory stiff-person syndrome (SPS). To investigate clinical and immunological effects of anti-CD19 CAR T cell use in treatment-refractory SPS, a 69-y-old female with a 9-y history of treatment-refractory SPS with deteriorating episodes of stiffness received an infusion of autologous anti-CD19 CAR T cells (KYV-101) and was monitored clinically and immunologically for more than 6 mo. CAR T cell infusion resulted in reduced leg stiffness, drastic improvement in gait, walking speed increase over 100%, and daily walking distance improvement from less than 50 m to over 6 km within 3 mo. GABAergic medication (benzodiazepines) was reduced by 40%. KYV-101 CAR T cells were well tolerated with only low-grade cytokine release syndrome. This report of successful use of anti-CD19 CAR T cells in treatment-refractory SPS supports continued exploration of this approach in SPS and other B cell–related autoimmune disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stiff-Person SyndromeImmunotherapy, AdoptiveAntigens, CD19HumansFemaleAgedReceptors, Chimeric AntigenT-LymphocytesTreatment Outcome

Stichwörter der Autor:innen

B cell autoimmunityCAR T cellschimeric antigen receptorneuroimmunological disorderstiff-person syndrome

Substanzen

Antigens, CD19Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum 44791, Germany.
  • Department of Neurology, Jena University Hospital, Jena 07747, Germany.
  • Department of Neurology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39120, Germany.
  • Department of Hematology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39120, Germany.
  • Kyverna Therapeutics, Emeryville, CA 94608.
  • Department of Haematology and Oncology, Ruhr-University Bochum, Knappschaftskrankenhaus Bochum, Bochum 44892, Germany.

ORCID-Profile: Simon Faissner, Jeremias Motte, Christian Geis, Aiden Haghikia, Dominic Borie, Roland Schroers, Ralf Gold

Förderung

  • Rose Foundation
  • Nasch family

Zitieren

APA

Faissner, S., Motte, J., Sgodzai, M., Geis, C., Haghikia, A., Mougiakakos, D., Borie, D., Schroers, R., & Gold, R. (2024). Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences, 121(26). https://doi.org/10.1073/pnas.2403227121

Vancouver

Faissner S, Motte J, Sgodzai M, Geis C, Haghikia A, Mougiakakos D, et al. Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome. Proceedings of the National Academy of Sciences. 2024;121(26). doi:10.1073/pnas.2403227121

BibTeX
@article{Faissner2024,
  author = {Faissner, Simon and Motte, Jeremias and Sgodzai, Melissa and Geis, Christian and Haghikia, Aiden and Mougiakakos, Dimitrios and Borie, Dominic and Schroers, Roland and Gold, Ralf},
  title = {Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {26},
  doi = {10.1073/pnas.2403227121}
}
Kostenlos starten →